Goal

Our goal is to close the gap between antibody discovery and therapeutic antibody development by developing next generation therapeutic antibodies. We have established unique platforms for antibody development that apply a combination of computer-aided design and traditional antibody discovery technologies. We believe in a “quality by design” concept and work to create novel therapeutic antibodies that can target difficult-to-treat cancers and CNS diseases.

shape

Gallery

shape shape